Mouse B cell activation is inhibited by CD44 cross-linking

Immunological Investigations

Volumn 34, Issue 4, 2005, Pages 399-416

  Wyant, Tiana L ^a   Fisher, Michael T ^a   McKallip, Robert J ^a   Nagarkatti, Prakash S ^a   Nagarkatti, Mitzi ^a   Conrad, Daniel H ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Adhesion receptor; B cell; CD44; IgE; Inflammation

Indexed keywords

CD40 LIGAND; FC GAMMA RECEPTOR II ANTIBODY; FC RECEPTOR; HERMES ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN F(AB) FRAGMENT; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY IM7; MONOCLONAL ANTIBODY RK3G9; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; IMMUNOGLOBULIN PRODUCTION; INHIBITION KINETICS; LIGAND BINDING; LYMPHOCYTE ACTIVATION; METASTASIS; MOUSE; NONHUMAN; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; PROTEIN CROSS LINKING;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD44; B-LYMPHOCYTES; CD40 LIGAND; FEMALE; IMMUNOGLOBULINS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; RECEPTORS, IGG;

EID: 27644591036     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.1080/08820130500265406     Document Type: Article

References (66)

1. Aarvak, T., Natvig, J. B. (2001). Cell-cell interactions in synovitis: antigen presenting cells and T cell interaction in rheumatoid arthritis. Arthritis Res. 3(1):13-17.
2. Akira, S., Takeda, K. (2004). Toll-like receptor signalling. Nat. Rev. Immunol. 4(7):499-511.
3. Arch, R., Wirth, K., Hofmann, M., Ponta, H., Matzku, S., Herrlich, P., Zoller, M. (1992). Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 257(5070):682-685.
4. Bradl, H., Schuh, W., Jack, H. M. (2004). CD44 is dispensable for B lymphopoiesis. Immunol. Lett. 95(1):71-75.
5. Butcher, E. C., Picker, L. J. (1996). Lymphocyte homing and homeostasis. Science 272(5258):60-66.
6. Camp, R. L., Kraus, T. A., Birkeland, M. L., Pure, E. (1991). High levels of CD44 expression distinguish virgin from antigen-primed B cells. J. Exp. Med. 173(3):763-766.
7. Carter, W. G. (1982). The cooperative role of the transformation- sensitive glycoproteins, GP140 and fibronectin, in cell attachment and spreading. J. Biol. Chem. 257(6):3249-3257.
8. Carter, W. G., Wayner, E. A. (1988). Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells. J. Biol. Chem. 263(9):4193-4201.
9. Chen, D., McKallip, R. J., Zeytun, A., Do, Y., Lombard, C., Robertson, J. L., Mak, T. W., Nagarkatti, P. S., Nagarkatti, M. (2001). CD44-deficient mice exhibit enhanced hepatitis after concanavalin A injection: evidence for involvement of CD44 in activation-induced cell death. J. Immunol. 166(10):5889-5897.
10. Cho, S. W., Kilmon, M. A., Studer, E. J., van der, P. H., Conrad, D. H. (1997). B cell activation and Ig, especially IgE, production is inhibited by high CD23 levels in vivo and in vitro. Cell. Immunol. 180(1):36-46.
11. Clark, R. A., Alon, R., Springer, T. A. (1996). CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma. J. Cell Biol. 134(4):1075-1087.
12. Dahlenborg, K., Pound, J. D., Gordon, J., Borrebaeck, C. A., Carlsson, R. (1997). Terminal differentiation of human germinal center B cells in vitro. Cell. Immunol. 175(2):141-149.
13. Dal Porto, J. M., Gauld, S. B., Merrell, K. T., Mulls, D., Pugh-Bernard, A. E., Cambier, J. (2004). B cell antigen receptor signaling 101. Mol. Immunol. 41(6-7):599-613.
14. Denning, S. M., Le, P. T., Singer, K. H., Haynes, B. F. (1990). Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation. J. Immunol. 144(1):7-15.
15. Feuillard, J., Taylor, D., Casamayor-Palleja, M., Johnson, G. D., MacLennan, I. C. (1995). Isolation and characteristics of tonsil centroblasts with reference to Ig class switching. Int. Immunol. 7(1):121-130.
16. Flanagan, B. F., Dalchau, R., Allen, A. K., Daar, A. S., Fabre, J. W. (1989). Chemical composition and tissue distribution of the human CDw44 glycoprotein. Immunology 67(2):167-175.
17. Foster, L. C., Arkonac, B. M., Sibinga, N. E., Shi, C., Perrella, M. A., Haber, E. (1998). Regulation of CD44 gene expression by the proinflammatory cytokine interleukin1beta in vascular smooth muscle cells. J. Biol. Chem. 273(32):20341-20346.
18. Galandrini, R., Albi, N., Tripodi, G., Zarcone, D., Terenzi, A., Moretta, A., Grossi, C. E., Velardi, A. (1993). Antibodies to CD44 trigger effector functions of human T cell clones. J. Immunol. 150(10):4225-4235.
19. Gauld, S. B., Dal Porto, J. M., Cambier, J. C. (2002). B cell antigen receptor signaling: roles in cell development and disease. Science 296(5573):1641-1642.
20. Guo, Y. J., Wong, J. H., Lin, S. C., Aruffo, A., Stamenkovic, I., Sy, M. S. (1994). Disruption of T lymphocyte reappearance in anti-Thy-1-treated animals in vivo with soluble CD44 and L-selectin molecules. Cell. Immunol. 154(1):202-218.
21. Guo, Y., Wu, Y., Shinde, S., Sy, M. S., Aruffo, A., Liu, Y. (1996). Identification of a costimulatory molecule rapidly induced by CD40L as CD44H. J. Exp. Med. 184(3):955-961.
22. Harnett, M. M. (2004). CD40: a growing cytoplasmic tale. Sci. STKE 237:e25.
23. Hasbold, J., Lyons, A. B., Kehry, M. R., Hodgkin, P. D. (1998). Cell division number regulates IgG1 and IgE switching of B cells following stimulation by CD40 ligand and IL-4. Eur. J. Immunol. 28(3):1040-1051.
24. Haynes, B. F., Telen, M. J., Hale, L. P., Denning, S. M. (1989). CD44-a molecule involved in leukocyte adherence and T-cell activation. Immunol. Today 10(12):423-428.
25. Haynes, B. F., Hale, L. P., Patton, K. L., Martin, M. E., McCallum, R. M. (1991). Measurement of an adhesion molecule as an indicator of inflammatory disease activity. Up-regulation of the receptor for hyaluronate (CD44) in rheumatoid arthritis. Arthritis Rheum. 34(11):1434-1443.
26. Hogerkorp, C. M., Bilke, S., Breslin, T., Ingvarsson, S., Borrebaeck, C. A. (2003). CD44-stimulated human B cells express transcripts specifically involved in immunomodulation and inflammation as analyzed by DNA microarrays. Blood 101(6):2307-2313.
27. Huet, S., Groux, H., Caillou, B., Valentin, H., Prieur, A. M., Bernard, A. (1989). CD44 contributes to T cell activation. J. Immunol. 143(3):798-801.
28. Ilangumaran, S., Briol, A., Hoessli, D. C. (1998). CD44 selectively associates with active Src family protein tyrosine kinases Lck and Fyn in glycosphingolipid-rich plasma membrane domains of human peripheral blood lymphocytes. Blood 91(10):3901-3908.
29. Ingvarsson, S., Dahlenborg, K., Carlsson, R., Borrebaeck, C. A. (1999). Co-ligation of CD44 on naive human tonsillar B cells induces progression towards a germinal center phenotype. Int. Immunol. 11(5):739-744.
30. Kelleher, D., Murphy, A., Feighery, C., Casey, E. B. (1995). Leukocyte function-associated antigen 1 (LFA-1) and CD44 are signalling molecules for cytoskeleton-dependent morphological changes in activated T cells. J. Leukoc. Biol. 58(5):539-546.
31. Khaldoyanidi, S., Moll, J., Karakhanova, S., Herrlich, P., Ponta, H. (1999). Hyaluronate-enhanced hematopoiesis: two different receptors trigger the release of interleukin-1beta and interleukin-6 from bone marrow macrophages. Blood 94(3):940-949.
32. Kim, J. H., Glant, T. T., Lesley, J., Hyman, R., Mikecz, K. (2000). Adhesion of lymphoid cells to CD44-specific substrata: the consequences of attachment depend on the ligand. Exp. Cell Res. 256(2):445-453.
33. Kincade, P. W., Zheng, Z., Katoh, S., Hanson, L. (1997). The importance of cellular environment to function of the CD44 matrix receptor. Curr. Opin. Cell Biol. 9(5):635-642.
34. Koyama, T., Yashiro, M., Inoue, T., Nishimura, S., Hirakawa-YS, Chung, K. (2000). TGF-beta1 secreted by gastric fibroblasts up-regulates CD44H expression and stimulates the peritoneal metastatic ability of scirrhous gastric cancer cells. Int. J. Oncol. 16(2):355-362.
35. Kremmidiotis, G., Zola, H. (1995). Changes in CD44 expression during B cell differentiation in the human tonsil. Cell. Immunol. 161(2):147-157.
36. Lazaar, A. L., Pure, E. (1995). CD44: a model for regulated adhesion function. Immunologist 3:19.
37. Lesley, J., Hyman, R. (1998). CD44 structure and function. Front Biosci. 3:d616-d630.
38. Lesley, J., He, Q., Miyake, K., Hamann, A., Hyman, R., Kincade, P. W. (1992). Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody. J. Exp. Med. 175(1):257-266.
39. Lesley, J., Hyman, R., Kincade, P. W. (1993). CD44 and its interaction with extracellular matrix. Adv. Immunol. 54:271-335.
40. Lindhout, E., van Eijk, M., van Pel, M., Lindeman, J., Dinant, H. J., de Groot, C. (1999). Fibroblast-like synoviocytes from rheumatoid arthritis patients have intrinsic properties of follicular dendritic cells. J. Immunol. 162(10):5949-5956.
41. McKallip, R. J., Do, Y., Fisher, M. T., Robertson, J. L., Nagarkatti, P. S., Nagarkatti, M. (2002). Role of CD44 in activation-induced cell death: CD44-deficient mice exhibit enhanced T cell response to conventional and superantigens. Int. Immunol. 14(9):1015-1026.
42. McKee, C. M., Penno, M. B., Cowman, M., Burdick, M. D., Strieter, R. M., Bao, C., Noble, P. W. (1996). Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J. Clin. Invest. 98(10):2403-2413.
43. Mikecz, K., Dennis, K., Shi, M., Kim, J. H. (1999). Modulation of hyaluronan receptor (CD44) function in vivo in a murine model of rheumatoid arthritis. Arthritis Rheum. 42(4):659-668.
44. Miyake, K., Underbill, C. B., Lesley, J., Kincade, P. W. (1990). Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J. Exp. Med. 172(1):69-75.
45. Murakami, S., Miyake, K., June, C. H., Kincade, P. W., Hodes, R. J. (1990). IL-5 induces a Pgp-1 (CD44) bright B cell subpopulation that is highly enriched in proliferative and Ig secretory activity and binds to hyaluronate. J. Immunol. 145(11):3618-3627.
46. Naor, D., Nedvetzki, S. (2003). CD44 in rheumatoid arthritis. Arthritis Res. Ther. 5(3):105-115.
47. Naor, D., Sionov, R. V., Ish-Shalom, D. (1997). CD44: structure, function, and association with the malignant process. Adv. Cancer Res. 71:241-319.
48. Naor, D., Nedvetzki, S., Golan, I., Melnik, L., Faitelson, Y. (2002). CD44 in cancer. Crit. Rev. Clin. Lab. Sci. 39(6):527-579.
49. Oliferenko, S., Paiha, K., Harder, T., Gerke, V., Schwarzler, C., Schwarz, H., Beug, H., Gunthert, U., Huber, L. A. (1999). Analysis of CD44-containing lipid rafts: recruitment of annexin II and stabilization by the actin cytoskeleton. J. Cell Biol. 146(4):843-854.
50. Payet, M. E., Woodward, E. C., Conrad, D. H. (1999). Humoral response suppression observed with CD23 transgenics. J. Immunol. 163(1):217-223.
51. Picker, L. J., De Los, T. J., Telen, M. J., Haynes, B. F., Butcher, E. C. (1989). Monoclonal antibodies against the CD44 [In(Lu)-related p80], and Pgp-1 antigens in man recognize the Hermes class of lymphocyte homing receptors. J. Immunol. 142(6):2046-2051.
52. Pierres, A., Lipcey, C., Mawas, C., Olive, D. (1992). A unique CD44 monoclonal antibody identifies a new T cell activation pathway. Eur. J. Immunol. 22(2):413-417.
53. Rabah, D., Conrad, D. H. (2002). Effect of cell density on in vitro mouse immunoglobulin E production. Immunology 106(4):503-510.
54. Rafi, A., Nagarkatti, M., Nagarkatti, P. S. (1997). Hyaluronate-CD44 interactions can induce murine B-cell activation. Blood 89(8):2901-2908.
55. Rao, M., Knox, R., Conrad, D. H. (1991). Characterization of Pgp-1 antigen on murine B lymphocytes using a new anti-Pgp-1 monoclonal antibody. Hybridoma 10(2):281-284.
56. Santos-Argumedo, L., Kincade, P. W., Partida-Sanchez, S., Parkhouse, R. M. (1997). CD44-stimulated dendrite formation ('spreading') in activated B cells. Immunology 90(1):147-153.
57. Schadt, E. E., Li, C., Su, C., Wong, W. H. (2000). Analyzing high-density oligonucleotide gene expression array data. J. Cell. Biochem. 80(2):192-202.
58. Seth, A., Gote, L., Nagarkatti, M., Nagarkatti, P. S. (1991). T-cell-receptor-independent activation of cytolytic activity of cytotoxic T lymphocytes mediated through CD44 and gp90MEL-14. Proc. Natl. Acad. Sci. U. S. A. 88(17):7877-7881.
59. Shimizu, Y., Van Seventer, G. A., Siraganian, R., Wahl, L., Shaw, S. (1989). Dual role of the CD44 molecule in T cell adhesion and activation. J. Immunol. 143(8):2457-2463.
60. Sleeman, J., Rudy, W., Hofmann, M., Moll, J., Herrlich, P., Ponta, H. (1996). Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity. J. Cell Biol. 135(4):1139-1150.
61. Taher, T. E., Smit, L., Griffioen, A. W., Schilder-Tol, E. J., Borst, J., Pals, S. T. (1996). Signaling through CD44 is mediated by tyrosine kinases. Association with p56lck in T lymphocytes. J. Biol. Chem. 271(5):2863-2867.
62. Tan, P. H., Santos, E. B., Rossbach, H. C., Sandmaier, B. M. (1993). Enhancement of natural killer activity by an antibody to CD44. J. Immunol. 150(3):812-820.
63. Turley, E. A., Noble, P. W., Bourguignon, L. Y. (2002). Signaling properties of hyaluronan receptors. J. Biol. Chem. 277(7):4589-4592.
64. Webb, D. S., Shimizu, Y., Van Seventer, G. A., Shaw, S., Gerrard, T. L. (1990). LFA-3, CD44, and CD45: physiologic triggers of human monocyte TNF and IL-1 release. Science 249(4974):1295-1297.
65. Zhang, M., Wang, M. H., Singh, R. K., Wells, A., Siegal, G. P. (1997). Epidermal growth factor induces CD44 gene expression through a novel regulatory element in mouse fibroblasts. J. Biol. Chem. 272(22):14139-14146.
66. Zheng, Z., Katoh, S., He, Q., Oritani, K., Miyake, K., Lesley, J., Hyman, R., Hamik, A., Parkhouse, R. M., Farr, A. G. (1995). Monoclonal antibodies to CD44 and their influence on hyaluronan recognition. J. Cell Biol. 130(2):485-495.